Skip to Content

Tag: A1C


Also Noted

Study: Dexcom G7 improves A1C in Type 2 diabetes

October 21, 2026HME News Staff

SAN DIEGO – Dexcom G7 users experienced an average 1.6% A1C reduction from a mean baseline of 8.8%, a 0.9% greater reduction compared with routine care, according to the results from the CONNECT randomized controlled trial published The New England Journal of Medicine. Dexcom G7 users also spent approximately five additional hours per day in the glucose target range of 70–180 mg/dL compared with those receiving routine care. “Publication of CONNECT in The New England Journal of...

A1C, Dexcom, Insulin pump, Type 2 Diabetes


Read Full Articlered right arrow icon